Sign In
Buy PTC
$139.72
-2.62 (-1.84%)
At Close: Jun 03, 2026
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Wednesday, 01'st Oct 2025
WARREN, N.J. , Oct. 1, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Sept.
PTC Delivers New Service Lifecycle Management AI Solutions to Modernize Field Service and the Service Supply Chain
08:30am, Tuesday, 30'th Sep 2025
Agentic AI advancements in ServiceMax AI accelerate work order execution and enable improvements in first-time fix rates Agentic AI advancements in Servigistics expand AI-driven intelligence for servi
3 Reasons Growth Investors Will Love PTC Inc. (PTC)
01:46pm, Tuesday, 23'rd Sep 2025
PTC Inc. (PTC) possesses solid growth attributes, which could help it handily outperform the market.
PTC Unveils Arena AI Assistant & Supply Chain Intelligence Enhancements
10:51am, Friday, 19'th Sep 2025
PTC expands its Arena portfolio with an AI-powered assistant, new supply chain tools and CAD-PLM integration to boost collaboration and efficiency.
PTC Launches Arena AI Assistant to Accelerate PLM and QMS Workflows
08:30am, Tuesday, 16'th Sep 2025
Conversational AI assistant answers users' questions and delivers step-by-step guidance for all experience levels Configurable interface conveniently embeds Arena AI Assistant in the context of produc
3 Software Stocks to Watch Closely in a Thriving Industry
10:51am, Monday, 15'th Sep 2025
Steady digital transformation and strong adoption of AI bode well for Computer Software industry participants like MSFT, PTC and MANH amid broader market volatility.
3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
03:41am, Friday, 12'th Sep 2025
These three companies are distinct, and their stocks present a range of risk-reward considerations for investors. I'm going to run through them in ascending order of risk and reward potential, so indu
PTC Therapeutics Could Challenge BioMarin For Metabolic Disorder Treatment
01:56pm, Monday, 08'th Sep 2025
On Saturday, BioMarin Pharmaceutical Inc. BMRN released new Phase 3 PEGASUS study results on Saturday.
Here's Why Shares in PTC Therapeutics Soared This Week
08:35am, Friday, 05'th Sep 2025
Shares in PTC Therapeutics (PTCT 4.43%) surged by 17.5% in the week to Friday morning, as the market digested management's upbeat presentation at the Cantor Global Healthcare Conference on Wednesday.
PTC Inc. (PTC) Inc. Presents At Citi's 2025 Global Technology, Media And Telecommunications Conference Transcript
03:40pm, Thursday, 04'th Sep 2025
PTC Inc. (NASDAQ:PTC ) Inc. Citi's 2025 Global Technology, Media and Telecommunications Conference September 4, 2025 12:50 PM EDT Company Participants Neil Barua - President, CEO & Director Kristian T
Prediction: PTC Will Soar Over the Next 3 Years. Here's 1 Reason Why.
04:57pm, Tuesday, 02'nd Sep 2025
The market is underestimating the growth potential of industrial and manufacturing software company PTC (PTC -0.45%). Simply put, its key metric, namely its annual run rate (ARR), continues to grow at
PTC Inc. (PTC) Up 0.1% Since Last Earnings Report: Can It Continue?
12:36pm, Friday, 29'th Aug 2025
PTC Inc. (PTC) reported earnings 30 days ago. What's next for the stock?
AI Exposure Without the Hype: 3 ETFs That Offer Smarter AI Bets
08:10am, Monday, 25'th Aug 2025
Though it's far from a new approach, many exchange-traded funds (ETFs) aiming to provide exposure to the much-hyped artificial intelligence (AI) space tend to lean fairly heavily on a small number of
Here is Why Growth Investors Should Buy PTC Inc. (PTC) Now
01:45pm, Thursday, 21'st Aug 2025
PTC Inc. (PTC) possesses solid growth attributes, which could help it handily outperform the market.
PTC Therapeutics Stock Is Stuck In A Multi-Year Slump
10:00am, Thursday, 21'st Aug 2025
PTC Therapeutics PTCT is currently in the final 18th phase of its Adhishthana cycle on the weekly chart, and the outlook remains bleak. Signals point to prolonged underperformance, with weakness likel
